Dementia Australia Research Foundation Ltd
Board Interlocks (3 shared directors)
Giving Philosophy
The foundation's giving philosophy centers on building capacity in dementia research in Australia. They support innovative, scientifically meritorious projects with potential for direct, beneficial impact on people living with dementia, their families, and carers. A strong emphasis is placed on knowledge translation and the involvement of people impacted by dementia in the research process, while also striving for a cure and improving quality of care.
Tips for Applicants
Applicants should begin writing their application early, proofread carefully, and ensure language is appropriate (e.g., 'people living with dementia' instead of 'dementia sufferers'). They should tailor their Academic Career Summary (max 2 pages) to the application, removing irrelevant personal information and highlighting academic achievements, awards, and publications. Proposals should demonstrate scientific merit, clear methodology, innovation, and a plan for knowledge translation. Engage with your Research Office early for assistance and endorsement. Reviewers consider scientific merit (40%), applicant's track record (30% relative to opportunity), innovation/significance (20%), and knowledge translation (10%). Shortlisted applications also undergo a Dementia Advocate assessment, weighing importance and benefit (60%) and involvement of people impacted by the research (40%).
Programs & Opportunities (1)
Project Grants, Fellowships, Stipends, Travel Grants, and Research Translation Grants for dementia research
Notable Grants
- The Hazel Hawke Alzheimer's Research and Care Fund has supported 24 research projects focusing on dementia care research, prevention and management of Alzheimer's disease, and crucial services for people with dementia and their carers.
- Supported research areas include mood and behavior changes in dementia, repetitive negative thinking, connections between gut microbiome and dementia onset, dementia in children and adolescents, and development of protein nanocages for Alzheimer's treatment.
Financial History (7 years)
| Year | Revenue | Expenses | Assets | Surplus |
|---|---|---|---|---|
| 2023 | $4.6M | $4.3M | $17.5M | $966K |
| 2022 | $3.0M | $2.9M | $16.1M | $-1,365,336 |
| 2021 | $3.5M | $2.4M | $17.5M | $2.7M |
| 2020 | $3.0M | $2.4M | $14.2M | $260K |
| 2019 | $4.6M | $2.0M | $13.9M | $3.2M |
| 2018 | $3.1M | $1.3M | $11.0M | $2.0M |
| 2017 | $2.1M | $1.3M | $4.9M | $778K |
Community Evidence
External EvidenceIdentity
- GS ID
- AU-ABN-79081407534
- ABN
- 79081407534
- Sector
- health
- Website
- www.dementia.org.au/research
- Financial Year
- 2023
Focus Areas
Board & Leadership (7)
- chair
- director
- director
- director
- director
- director
- director
Financials
- Revenue
- $4.6M
- Assets
- $17.5M
Method
- Match Confidence
- registry
- Cross-references
- 2 datasets
- Match Key
- ABN
- Relationships
- 21
Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.
Data Sources
JusticeHub
External LinkThis entity is also tracked in JusticeHub with 0 interventions and 0 evidence records.
External ecosystem profile linked from GrantScope for additional context. JusticeHub content is maintained separately.
View on JusticeHubLocation Intelligence
- Postcode
- 2603
- Locality
- Griffith (ACT)
- Remoteness
- Major Cities of Australia
- SEIFA Disadvantage
- Decile 10/10
- LGA
- Unincorporated ACT
- SA2 Region
- Griffith (ACT)
- Entities in Area
- 544